Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.80390589 |
2 | cellular extravasation (GO:0045123) | 4.22082231 |
3 | positive regulation of granulocyte differentiation (GO:0030854) | 3.85346121 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 3.85194788 |
5 | modulation by symbiont of host defense response (GO:0052031) | 3.85194788 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.85194788 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.85194788 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.85194788 |
9 | modulation by symbiont of host immune response (GO:0052553) | 3.85194788 |
10 | histone H3-K4 trimethylation (GO:0080182) | 3.77063888 |
11 | response to interleukin-15 (GO:0070672) | 3.73204569 |
12 | tolerance induction (GO:0002507) | 3.70751039 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.67464472 |
14 | negative regulation of T cell mediated immunity (GO:0002710) | 3.67214557 |
15 | leukocyte aggregation (GO:0070486) | 3.61247583 |
16 | B cell receptor signaling pathway (GO:0050853) | 3.60931254 |
17 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.53819017 |
18 | macrophage activation involved in immune response (GO:0002281) | 3.48552077 |
19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45181367 |
20 | cellular response to interleukin-15 (GO:0071350) | 3.45018302 |
21 | T cell migration (GO:0072678) | 3.44557565 |
22 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.35663904 |
23 | microglial cell activation (GO:0001774) | 3.32058991 |
24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.31263683 |
25 | neutrophil mediated immunity (GO:0002446) | 3.30662423 |
26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.28345321 |
27 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.20749234 |
28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.20518579 |
29 | interferon-gamma production (GO:0032609) | 3.19622875 |
30 | hepatocyte apoptotic process (GO:0097284) | 3.15939263 |
31 | detection of other organism (GO:0098543) | 3.13353856 |
32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09837559 |
33 | response to peptidoglycan (GO:0032494) | 3.07954542 |
34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05685989 |
35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05685989 |
36 | myeloid leukocyte mediated immunity (GO:0002444) | 3.04539677 |
37 | regulation of granulocyte differentiation (GO:0030852) | 3.04464757 |
38 | activated T cell proliferation (GO:0050798) | 3.04325809 |
39 | detection of molecule of bacterial origin (GO:0032490) | 3.04153986 |
40 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.02177135 |
41 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.01658938 |
42 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99922721 |
43 | regulation of regulatory T cell differentiation (GO:0045589) | 2.99001288 |
44 | germinal center formation (GO:0002467) | 2.97165158 |
45 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96015597 |
46 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.95806543 |
47 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.95806543 |
48 | neutrophil activation involved in immune response (GO:0002283) | 2.95075190 |
49 | regulation of hypersensitivity (GO:0002883) | 2.92417012 |
50 | alpha-beta T cell differentiation (GO:0046632) | 2.91703411 |
51 | coronary vasculature morphogenesis (GO:0060977) | 2.90678330 |
52 | negative regulation of interleukin-12 production (GO:0032695) | 2.90062694 |
53 | macrophage activation (GO:0042116) | 2.89563271 |
54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88299494 |
55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.87725411 |
56 | response to host immune response (GO:0052572) | 2.87725411 |
57 | detection of bacterium (GO:0016045) | 2.85560354 |
58 | growth hormone receptor signaling pathway (GO:0060396) | 2.85465699 |
59 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.84888254 |
60 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.84819742 |
61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.84164545 |
62 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.83502547 |
63 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.83502547 |
64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83003954 |
65 | response to host (GO:0075136) | 2.83003954 |
66 | response to host defenses (GO:0052200) | 2.83003954 |
67 | response to type I interferon (GO:0034340) | 2.80990465 |
68 | alpha-beta T cell activation (GO:0046631) | 2.80849560 |
69 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.80685315 |
70 | T-helper cell differentiation (GO:0042093) | 2.80685315 |
71 | neutrophil activation (GO:0042119) | 2.80616930 |
72 | detection of external biotic stimulus (GO:0098581) | 2.80008599 |
73 | type I interferon signaling pathway (GO:0060337) | 2.79571132 |
74 | cellular response to type I interferon (GO:0071357) | 2.79571132 |
75 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.79421307 |
76 | histone H3-K36 demethylation (GO:0070544) | 2.78091498 |
77 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.77999439 |
78 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.77556803 |
79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77341304 |
80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.77328971 |
81 | phospholipid homeostasis (GO:0055091) | 2.76256316 |
82 | negative regulation of cell killing (GO:0031342) | 2.75761870 |
83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.75761870 |
84 | myeloid cell activation involved in immune response (GO:0002275) | 2.74616357 |
85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.68489250 |
86 | negative regulation of stress fiber assembly (GO:0051497) | 2.68453068 |
87 | negative regulation of B cell proliferation (GO:0030889) | 2.67807559 |
88 | positive regulation of interferon-alpha production (GO:0032727) | 2.67359941 |
89 | protein targeting to Golgi (GO:0000042) | 2.66186602 |
90 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.58603440 |
91 | phospholipid efflux (GO:0033700) | 2.57565129 |
92 | negative thymic T cell selection (GO:0045060) | 2.57459046 |
93 | negative T cell selection (GO:0043383) | 2.56553364 |
94 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.55885103 |
95 | positive thymic T cell selection (GO:0045059) | 2.54847976 |
96 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.53864871 |
97 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.53864871 |
98 | positive regulation of B cell differentiation (GO:0045579) | 2.52772601 |
99 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.52549443 |
100 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.50347328 |
101 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.50347328 |
102 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.50347328 |
103 | NIK/NF-kappaB signaling (GO:0038061) | 2.49599286 |
104 | thymic T cell selection (GO:0045061) | 2.49501802 |
105 | establishment of protein localization to Golgi (GO:0072600) | 2.48879993 |
106 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.45429398 |
107 | desmosome organization (GO:0002934) | 2.44470115 |
108 | T cell selection (GO:0045058) | 2.43925224 |
109 | positive regulation of respiratory burst (GO:0060267) | 2.43117345 |
110 | histone H3-K4 methylation (GO:0051568) | 2.39668087 |
111 | negative regulation of bone resorption (GO:0045779) | 2.38323945 |
112 | positive regulation of histone deacetylation (GO:0031065) | 2.36785090 |
113 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36211333 |
114 | cellular response to growth hormone stimulus (GO:0071378) | 2.35562697 |
115 | positive T cell selection (GO:0043368) | 2.35400855 |
116 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.35376962 |
117 | positive regulation of mRNA catabolic process (GO:0061014) | 2.34147570 |
118 | positive regulation of cholesterol efflux (GO:0010875) | 2.33916180 |
119 | negative regulation of lipid storage (GO:0010888) | 2.32718597 |
120 | peptidyl-lysine trimethylation (GO:0018023) | 2.31736500 |
121 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.29871654 |
122 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.29871654 |
123 | T cell differentiation involved in immune response (GO:0002292) | 2.29871654 |
124 | positive regulation of sterol transport (GO:0032373) | 2.27841934 |
125 | positive regulation of cholesterol transport (GO:0032376) | 2.27841934 |
126 | tryptophan metabolic process (GO:0006568) | 2.26944987 |
127 | regulation of cholesterol homeostasis (GO:2000188) | 2.25991700 |
128 | definitive hemopoiesis (GO:0060216) | 2.22372596 |
129 | regulation of bile acid biosynthetic process (GO:0070857) | 2.21924315 |
130 | tryptophan catabolic process (GO:0006569) | 2.20559766 |
131 | indole-containing compound catabolic process (GO:0042436) | 2.20559766 |
132 | indolalkylamine catabolic process (GO:0046218) | 2.20559766 |
133 | lymph vessel development (GO:0001945) | 2.19776063 |
134 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.19307953 |
135 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.18646591 |
136 | positive regulation of p38MAPK cascade (GO:1900745) | 2.16261595 |
137 | chemical homeostasis within a tissue (GO:0048875) | 2.16235550 |
138 | regulation of T cell tolerance induction (GO:0002664) | 2.15910514 |
139 | protein localization to endosome (GO:0036010) | 2.15316969 |
140 | cellular response to ethanol (GO:0071361) | 2.14204196 |
141 | I-kappaB phosphorylation (GO:0007252) | 2.12223262 |
142 | positive regulation of tolerance induction (GO:0002645) | 2.12199803 |
143 | regulation of RIG-I signaling pathway (GO:0039535) | 2.11536536 |
144 | negative regulation of lipase activity (GO:0060192) | 2.11133697 |
145 | regulation of B cell differentiation (GO:0045577) | 2.08988767 |
146 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.06263520 |
147 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.06207917 |
148 | regulation of tolerance induction (GO:0002643) | 2.05511945 |
149 | regulation of germinal center formation (GO:0002634) | 2.04885057 |
150 | surfactant homeostasis (GO:0043129) | 2.04768982 |
151 | regulation of mRNA catabolic process (GO:0061013) | 2.04200949 |
152 | transcytosis (GO:0045056) | 2.02734757 |
153 | plasma lipoprotein particle assembly (GO:0034377) | 2.01597416 |
154 | response to muramyl dipeptide (GO:0032495) | 2.01256315 |
155 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 1.99003358 |
156 | aromatic amino acid family catabolic process (GO:0009074) | 1.98816800 |
157 | protein carboxylation (GO:0018214) | 1.98478048 |
158 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.98478048 |
159 | urea cycle (GO:0000050) | 1.98135323 |
160 | urea metabolic process (GO:0019627) | 1.98135323 |
161 | negative regulation of bone remodeling (GO:0046851) | 1.97383790 |
162 | negative regulation of actin filament bundle assembly (GO:0032232) | 1.97200358 |
163 | hydrogen peroxide biosynthetic process (GO:0050665) | 1.96618923 |
164 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 1.96568118 |
165 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 1.96394622 |
166 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 1.96098193 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34372847 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.10301666 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.62898011 |
4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.35440115 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31665061 |
6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.29373095 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.22286597 |
8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.13264443 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.12748792 |
10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.11765561 |
11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.04716282 |
12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96268785 |
13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.93900015 |
14 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93216263 |
15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.91764639 |
16 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.91138967 |
17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89235695 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87712819 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.86880023 |
20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.86655188 |
21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83166456 |
22 | MYC_22102868_ChIP-Seq_BL_Human | 1.82627600 |
23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.80844947 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80117622 |
25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77858224 |
26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74491197 |
27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74292677 |
28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.69170377 |
29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68401585 |
30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67198739 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63679113 |
32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63191944 |
33 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61891339 |
34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58963525 |
35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58653322 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56362627 |
37 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.55413470 |
38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54929937 |
39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50288242 |
40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49673249 |
41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49437620 |
42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47658342 |
43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47448546 |
44 | TP53_16413492_ChIP-PET_HCT116_Human | 1.45696380 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40239209 |
46 | MAF_26560356_Chip-Seq_TH2_Human | 1.39949912 |
47 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39699559 |
48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39549828 |
49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34585436 |
50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33727367 |
51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33070046 |
52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.32594246 |
53 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32140976 |
54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31932131 |
55 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.31831868 |
56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31110730 |
57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30674795 |
58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29618268 |
59 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27846094 |
60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27458988 |
61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26889990 |
62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.26636038 |
63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26619279 |
64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25997244 |
65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25501278 |
66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25410615 |
67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23029490 |
68 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22978059 |
69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.22923185 |
70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22861950 |
71 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.22841404 |
72 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.20984655 |
73 | RXR_22108803_ChIP-Seq_LS180_Human | 1.20000500 |
74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18542236 |
75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16885832 |
76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12842889 |
77 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11596987 |
78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11037988 |
79 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.10981135 |
80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08681471 |
81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08106666 |
82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07209065 |
83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07209065 |
84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06824272 |
85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06494860 |
86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05548732 |
87 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.04218118 |
88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04024853 |
89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02150669 |
90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01974356 |
91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00168762 |
92 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.99454470 |
93 | MYB_26560356_Chip-Seq_TH1_Human | 0.99328718 |
94 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99263691 |
95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99117956 |
96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99080059 |
97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98756417 |
98 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98345494 |
99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98308649 |
100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98105211 |
101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97251726 |
102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96908191 |
103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96893430 |
104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.96129279 |
105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95191849 |
106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95012184 |
107 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94912217 |
108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94053164 |
109 | MYB_26560356_Chip-Seq_TH2_Human | 0.93917414 |
110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93802117 |
111 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93232792 |
112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92755637 |
113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91907497 |
114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90700566 |
115 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90261455 |
116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89982793 |
117 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89733513 |
118 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89609290 |
119 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.89581067 |
120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89524268 |
121 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88710173 |
122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88535262 |
123 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.87184095 |
124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86836675 |
125 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86836675 |
126 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86695064 |
127 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86612120 |
128 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.86284698 |
129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85611298 |
130 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85419115 |
131 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85002611 |
132 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84609089 |
133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84209134 |
134 | AR_25329375_ChIP-Seq_VCAP_Human | 0.83591515 |
135 | MAF_26560356_Chip-Seq_TH1_Human | 0.83249845 |
136 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82357367 |
137 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82357367 |
138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81362870 |
139 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81249077 |
140 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81244789 |
141 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.78414988 |
142 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.75505179 |
143 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.72587749 |
144 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.71732667 |
145 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68532052 |
146 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.67386635 |
147 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.66821093 |
148 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.65377652 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002254_reproductive_system_inflammat | 3.79600224 |
2 | MP0003300_gastrointestinal_ulcer | 3.08756129 |
3 | MP0005360_urolithiasis | 2.73032143 |
4 | MP0005365_abnormal_bile_salt | 2.61205246 |
5 | MP0002166_altered_tumor_susceptibility | 2.51582163 |
6 | MP0003252_abnormal_bile_duct | 2.37560482 |
7 | MP0004510_myositis | 2.36865078 |
8 | MP0001790_abnormal_immune_system | 2.36543329 |
9 | MP0005387_immune_system_phenotype | 2.36543329 |
10 | MP0008057_abnormal_DNA_replication | 2.36113467 |
11 | MP0002138_abnormal_hepatobiliary_system | 2.33997222 |
12 | MP0002139_abnormal_hepatobiliary_system | 2.31370267 |
13 | MP0005085_abnormal_gallbladder_physiolo | 2.20134966 |
14 | MP0000685_abnormal_immune_system | 2.18946675 |
15 | MP0002009_preneoplasia | 2.15937300 |
16 | MP0001873_stomach_inflammation | 2.13491179 |
17 | MP0001835_abnormal_antigen_presentation | 2.05861447 |
18 | MP0000703_abnormal_thymus_morphology | 2.02318397 |
19 | MP0003045_fibrosis | 1.99360037 |
20 | MP0001346_abnormal_lacrimal_gland | 1.97992760 |
21 | MP0002006_tumorigenesis | 1.95707164 |
22 | MP0001800_abnormal_humoral_immune | 1.83505505 |
23 | MP0003724_increased_susceptibility_to | 1.78969907 |
24 | MP0000689_abnormal_spleen_morphology | 1.76319560 |
25 | MP0004947_skin_inflammation | 1.75748635 |
26 | MP0002722_abnormal_immune_system | 1.74703945 |
27 | MP0003453_abnormal_keratinocyte_physiol | 1.66499214 |
28 | MP0010234_abnormal_vibrissa_follicle | 1.65719135 |
29 | MP0003828_pulmonary_edema | 1.64477186 |
30 | MP0003763_abnormal_thymus_physiology | 1.64278914 |
31 | MP0002723_abnormal_immune_serum | 1.57255751 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.56607736 |
33 | MP0002419_abnormal_innate_immunity | 1.54200905 |
34 | MP0000383_abnormal_hair_follicle | 1.53433237 |
35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.53194569 |
36 | MP0002452_abnormal_antigen_presenting | 1.52537603 |
37 | MP0002796_impaired_skin_barrier | 1.51750147 |
38 | MP0003183_abnormal_peptide_metabolism | 1.49529975 |
39 | MP0001851_eye_inflammation | 1.49115576 |
40 | MP0010678_abnormal_skin_adnexa | 1.47840663 |
41 | MP0005409_darkened_coat_color | 1.46814751 |
42 | MP0002998_abnormal_bone_remodeling | 1.46423400 |
43 | MP0005397_hematopoietic_system_phenotyp | 1.46301638 |
44 | MP0001545_abnormal_hematopoietic_system | 1.46301638 |
45 | MP0000569_abnormal_digit_pigmentation | 1.45916192 |
46 | MP0010329_abnormal_lipoprotein_level | 1.45649928 |
47 | MP0003172_abnormal_lysosome_physiology | 1.43903745 |
48 | MP0010368_abnormal_lymphatic_system | 1.43752631 |
49 | MP0000465_gastrointestinal_hemorrhage | 1.43091096 |
50 | MP0009764_decreased_sensitivity_to | 1.41744889 |
51 | MP0003191_abnormal_cellular_cholesterol | 1.41577452 |
52 | MP0009278_abnormal_bone_marrow | 1.40016706 |
53 | MP0003436_decreased_susceptibility_to | 1.39429400 |
54 | MP0005671_abnormal_response_to | 1.39337702 |
55 | MP0005076_abnormal_cell_differentiation | 1.39257526 |
56 | MP0005075_abnormal_melanosome_morpholog | 1.38849236 |
57 | MP0002420_abnormal_adaptive_immunity | 1.38827563 |
58 | MP0005310_abnormal_salivary_gland | 1.38256286 |
59 | MP0001819_abnormal_immune_cell | 1.37455960 |
60 | MP0008961_abnormal_basal_metabolism | 1.34428957 |
61 | MP0000015_abnormal_ear_pigmentation | 1.33216111 |
62 | MP0004185_abnormal_adipocyte_glucose | 1.32904441 |
63 | MP0005000_abnormal_immune_tolerance | 1.32669710 |
64 | MP0002877_abnormal_melanocyte_morpholog | 1.31860535 |
65 | MP0001666_abnormal_nutrient_absorption | 1.28798521 |
66 | MP0000609_abnormal_liver_physiology | 1.28304450 |
67 | MP0001879_abnormal_lymphatic_vessel | 1.27787695 |
68 | MP0001853_heart_inflammation | 1.27366973 |
69 | MP0003303_peritoneal_inflammation | 1.25397474 |
70 | MP0005464_abnormal_platelet_physiology | 1.24431848 |
71 | MP0002928_abnormal_bile_duct | 1.23828436 |
72 | MP0003868_abnormal_feces_composition | 1.21925154 |
73 | MP0009780_abnormal_chondrocyte_physiolo | 1.21609596 |
74 | MP0005451_abnormal_body_composition | 1.20071998 |
75 | MP0001216_abnormal_epidermal_layer | 1.19552321 |
76 | MP0004808_abnormal_hematopoietic_stem | 1.17742492 |
77 | MP0003656_abnormal_erythrocyte_physiolo | 1.16920945 |
78 | MP0010155_abnormal_intestine_physiology | 1.15348668 |
79 | MP0001845_abnormal_inflammatory_respons | 1.15252605 |
80 | MP0005167_abnormal_blood-brain_barrier | 1.15050562 |
81 | MP0005025_abnormal_response_to | 1.14956499 |
82 | MP0002060_abnormal_skin_morphology | 1.14776807 |
83 | MP0002971_abnormal_brown_adipose | 1.13507669 |
84 | MP0004381_abnormal_hair_follicle | 1.10196436 |
85 | MP0004883_abnormal_blood_vessel | 1.09731160 |
86 | MP0009115_abnormal_fat_cell | 1.09588516 |
87 | MP0000716_abnormal_immune_system | 1.07313415 |
88 | MP0002933_joint_inflammation | 1.04998034 |
89 | MP0002398_abnormal_bone_marrow | 1.04747741 |
90 | MP0002148_abnormal_hypersensitivity_rea | 1.04652346 |
91 | MP0000013_abnormal_adipose_tissue | 1.01143675 |
92 | MP0003091_abnormal_cell_migration | 0.99565741 |
93 | MP0006082_CNS_inflammation | 0.98889411 |
94 | MP0001533_abnormal_skeleton_physiology | 0.98883196 |
95 | MP0002118_abnormal_lipid_homeostasis | 0.98416376 |
96 | MP0003787_abnormal_imprinting | 0.98134234 |
97 | MP0005174_abnormal_tail_pigmentation | 0.95261970 |
98 | MP0009785_altered_susceptibility_to | 0.94658968 |
99 | MP0002405_respiratory_system_inflammati | 0.92403182 |
100 | MP0005666_abnormal_adipose_tissue | 0.90001912 |
101 | MP0000377_abnormal_hair_follicle | 0.89813445 |
102 | MP0001191_abnormal_skin_condition | 0.89746392 |
103 | MP0003943_abnormal_hepatobiliary_system | 0.88887030 |
104 | MP0008260_abnormal_autophagy | 0.87867314 |
105 | MP0008469_abnormal_protein_level | 0.86202732 |
106 | MP0004264_abnormal_extraembryonic_tissu | 0.86117892 |
107 | MP0002396_abnormal_hematopoietic_system | 0.85983263 |
108 | MP0004130_abnormal_muscle_cell | 0.85505184 |
109 | MP0005375_adipose_tissue_phenotype | 0.84914076 |
110 | MP0002132_abnormal_respiratory_system | 0.83597852 |
111 | MP0002332_abnormal_exercise_endurance | 0.83543989 |
112 | MP0003866_abnormal_defecation | 0.83366658 |
113 | MP0003646_muscle_fatigue | 0.83150875 |
114 | MP0008877_abnormal_DNA_methylation | 0.82024159 |
115 | MP0005164_abnormal_response_to | 0.80753923 |
116 | MP0000767_abnormal_smooth_muscle | 0.80407743 |
117 | MP0000858_altered_metastatic_potential | 0.79967806 |
118 | MP0004019_abnormal_vitamin_homeostasis | 0.79807984 |
119 | MP0002098_abnormal_vibrissa_morphology | 0.79481522 |
120 | MP0000003_abnormal_adipose_tissue | 0.75366657 |
121 | MP0008995_early_reproductive_senescence | 0.74981865 |
122 | MP0004484_altered_response_of | 0.73874229 |
123 | MP0002019_abnormal_tumor_incidence | 0.73208566 |
124 | MP0002168_other_aberrant_phenotype | 0.73022843 |
125 | MP0003941_abnormal_skin_development | 0.72925366 |
126 | MP0002429_abnormal_blood_cell | 0.71285274 |
127 | MP0008004_abnormal_stomach_pH | 0.68903206 |
128 | MP0000249_abnormal_blood_vessel | 0.67888079 |
129 | MP0003448_altered_tumor_morphology | 0.67025440 |
130 | MP0009763_increased_sensitivity_to | 0.64177709 |
131 | MP0002277_abnormal_respiratory_mucosa | 0.63901055 |
132 | MP0009765_abnormal_xenobiotic_induced | 0.62419076 |
133 | MP0000371_diluted_coat_color | 0.57002943 |
134 | MP0005390_skeleton_phenotype | 0.55152986 |
135 | MP0003690_abnormal_glial_cell | 0.54238004 |
136 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53577855 |
137 | MP0001765_abnormal_ion_homeostasis | 0.53218630 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of the fingertips (HP:0001211) | 4.87583316 |
2 | Eczematoid dermatitis (HP:0000976) | 4.00655697 |
3 | Orchitis (HP:0100796) | 3.68979676 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.66425161 |
5 | Autoimmune thrombocytopenia (HP:0001973) | 3.55308787 |
6 | Gastrointestinal infarctions (HP:0005244) | 3.43042373 |
7 | Abnormality of T cells (HP:0002843) | 3.43033006 |
8 | Myocardial infarction (HP:0001658) | 3.31343771 |
9 | Recurrent bacterial skin infections (HP:0005406) | 3.13480508 |
10 | Leukocytosis (HP:0001974) | 3.05446409 |
11 | Recurrent viral infections (HP:0004429) | 3.01847075 |
12 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.95045229 |
13 | Recurrent fungal infections (HP:0002841) | 2.94929573 |
14 | Lip pit (HP:0100267) | 2.94346935 |
15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.90271521 |
16 | Spontaneous hematomas (HP:0007420) | 2.84976104 |
17 | Abnormality of macrophages (HP:0004311) | 2.83493446 |
18 | Chest pain (HP:0100749) | 2.80021085 |
19 | Colitis (HP:0002583) | 2.70544221 |
20 | Abnormality of T cell physiology (HP:0011840) | 2.69476506 |
21 | Deep venous thrombosis (HP:0002625) | 2.62422480 |
22 | Papilledema (HP:0001085) | 2.62338674 |
23 | Severe combined immunodeficiency (HP:0004430) | 2.60711498 |
24 | Hemoptysis (HP:0002105) | 2.60220215 |
25 | Gingival bleeding (HP:0000225) | 2.58565483 |
26 | Recurrent bronchitis (HP:0002837) | 2.57474677 |
27 | Toxemia of pregnancy (HP:0100603) | 2.55184602 |
28 | Keratoconjunctivitis (HP:0001096) | 2.54484194 |
29 | Panhypogammaglobulinemia (HP:0003139) | 2.53877235 |
30 | Viral hepatitis (HP:0006562) | 2.53170558 |
31 | Chronic otitis media (HP:0000389) | 2.50883124 |
32 | Mitral stenosis (HP:0001718) | 2.50246022 |
33 | Ectropion (HP:0000656) | 2.48883723 |
34 | Stomach cancer (HP:0012126) | 2.46579245 |
35 | Subacute progressive viral hepatitis (HP:0006572) | 2.46339325 |
36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46043909 |
37 | Obstructive lung disease (HP:0006536) | 2.43073907 |
38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43073907 |
39 | Recurrent abscess formation (HP:0002722) | 2.41516518 |
40 | Abnormality of T cell number (HP:0011839) | 2.40244506 |
41 | Agammaglobulinemia (HP:0004432) | 2.39374775 |
42 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.36675199 |
43 | Prolonged partial thromboplastin time (HP:0003645) | 2.36300334 |
44 | Inflammation of the large intestine (HP:0002037) | 2.31660589 |
45 | Recurrent skin infections (HP:0001581) | 2.23907306 |
46 | Arterial thrombosis (HP:0004420) | 2.23875577 |
47 | Increased IgE level (HP:0003212) | 2.23776795 |
48 | Chronic diarrhea (HP:0002028) | 2.22582900 |
49 | Eosinophilia (HP:0001880) | 2.22130653 |
50 | Neonatal hypoglycemia (HP:0001998) | 2.18544716 |
51 | Mediastinal lymphadenopathy (HP:0100721) | 2.17797232 |
52 | Hypochromic anemia (HP:0001931) | 2.16390275 |
53 | Truncal obesity (HP:0001956) | 2.14385561 |
54 | Hyperkalemia (HP:0002153) | 2.14224062 |
55 | Hematochezia (HP:0002573) | 2.14017363 |
56 | Thick nail (HP:0001805) | 2.12213075 |
57 | IgG deficiency (HP:0004315) | 2.11848729 |
58 | T lymphocytopenia (HP:0005403) | 2.10404858 |
59 | Hypoalphalipoproteinemia (HP:0003233) | 2.10023933 |
60 | Stomatitis (HP:0010280) | 2.09190753 |
61 | Autoimmune hemolytic anemia (HP:0001890) | 2.08828461 |
62 | Lymphopenia (HP:0001888) | 2.08635458 |
63 | Portal hypertension (HP:0001409) | 2.08604860 |
64 | Gingivitis (HP:0000230) | 2.08227263 |
65 | Acute myeloid leukemia (HP:0004808) | 2.07688005 |
66 | Xanthomatosis (HP:0000991) | 2.07427928 |
67 | Polycythemia (HP:0001901) | 2.07425558 |
68 | Alveolar cell carcinoma (HP:0006519) | 2.07100484 |
69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05324686 |
70 | Abnormality of the hepatic vasculature (HP:0006707) | 2.04253954 |
71 | Intrahepatic cholestasis (HP:0001406) | 2.03993814 |
72 | Hypochromic microcytic anemia (HP:0004840) | 2.03849447 |
73 | Thyroiditis (HP:0100646) | 2.03830520 |
74 | Narrow palate (HP:0000189) | 2.03699111 |
75 | Entropion (HP:0000621) | 2.02990848 |
76 | Gangrene (HP:0100758) | 2.01488657 |
77 | Verrucae (HP:0200043) | 2.00824450 |
78 | Papilloma (HP:0012740) | 2.00824450 |
79 | Absent frontal sinuses (HP:0002688) | 2.00227654 |
80 | Gastrointestinal inflammation (HP:0004386) | 1.99356053 |
81 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99245531 |
82 | Vasculitis (HP:0002633) | 1.99212889 |
83 | Esophageal varix (HP:0002040) | 1.98416199 |
84 | Hyperlipoproteinemia (HP:0010980) | 1.97787011 |
85 | Hyperglycemia (HP:0003074) | 1.97028682 |
86 | Abnormality of the pleura (HP:0002103) | 1.95836845 |
87 | Encephalitis (HP:0002383) | 1.95775136 |
88 | Spondylolisthesis (HP:0003302) | 1.95619830 |
89 | Abnormality of the columella (HP:0009929) | 1.92932164 |
90 | Cellulitis (HP:0100658) | 1.92763739 |
91 | Abnormality of the prostate (HP:0008775) | 1.92099581 |
92 | Fatigue (HP:0012378) | 1.91848327 |
93 | Milia (HP:0001056) | 1.91372178 |
94 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91056466 |
95 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91056466 |
96 | Anorexia (HP:0002039) | 1.90342444 |
97 | Long eyelashes (HP:0000527) | 1.88426178 |
98 | Combined immunodeficiency (HP:0005387) | 1.87257065 |
99 | Hypergammaglobulinemia (HP:0010702) | 1.86833467 |
100 | Joint swelling (HP:0001386) | 1.86274429 |
101 | Increased IgM level (HP:0003496) | 1.85971249 |
102 | Prolonged bleeding time (HP:0003010) | 1.85882871 |
103 | Abnormality of B cell number (HP:0010975) | 1.85372219 |
104 | B lymphocytopenia (HP:0010976) | 1.85372219 |
105 | * Slow saccadic eye movements (HP:0000514) | 1.82628648 |
106 | Urticaria (HP:0001025) | 1.82140367 |
107 | Abnormality of proline metabolism (HP:0010907) | 1.81561193 |
108 | Hydroxyprolinuria (HP:0003080) | 1.81561193 |
109 | Myositis (HP:0100614) | 1.81524745 |
110 | Retrobulbar optic neuritis (HP:0100654) | 1.81078867 |
111 | Optic neuritis (HP:0100653) | 1.81078867 |
112 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.80992505 |
113 | Syringomyelia (HP:0003396) | 1.80661383 |
114 | Spinal cord lesions (HP:0100561) | 1.80661383 |
115 | Dislocated radial head (HP:0003083) | 1.80232273 |
116 | Osteomyelitis (HP:0002754) | 1.80079899 |
117 | Conjugated hyperbilirubinemia (HP:0002908) | 1.79928843 |
118 | Joint hemorrhage (HP:0005261) | 1.79774173 |
119 | Hypoglycemic coma (HP:0001325) | 1.79384660 |
120 | Granulocytopenia (HP:0001913) | 1.79250546 |
121 | Axonal loss (HP:0003447) | 1.79112570 |
122 | Periodontitis (HP:0000704) | 1.79103255 |
123 | Hypoplasia of the thymus (HP:0000778) | 1.78137509 |
124 | Prominent nose (HP:0000448) | 1.77541108 |
125 | Hypercholesterolemia (HP:0003124) | 1.77232291 |
126 | Abnormality of eosinophils (HP:0001879) | 1.75825818 |
127 | Epistaxis (HP:0000421) | 1.75737510 |
128 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.75019080 |
129 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.74558770 |
130 | Meningitis (HP:0001287) | 1.73748326 |
131 | Pulmonary embolism (HP:0002204) | 1.73270032 |
132 | Limb hypertonia (HP:0002509) | 1.72779220 |
133 | Sepsis (HP:0100806) | 1.72350034 |
134 | Abnormality of the nasal septum (HP:0000419) | 1.71843042 |
135 | IgM deficiency (HP:0002850) | 1.71429863 |
136 | Pustule (HP:0200039) | 1.71297527 |
137 | Decreased circulating renin level (HP:0003351) | 1.71099745 |
138 | Pulmonary infiltrates (HP:0002113) | 1.71014440 |
139 | Keratoconjunctivitis sicca (HP:0001097) | 1.68628178 |
140 | Urethral obstruction (HP:0000796) | 1.68036578 |
141 | Homocystinuria (HP:0002156) | 1.66937501 |
142 | Abnormality of homocysteine metabolism (HP:0010919) | 1.66937501 |
143 | Alopecia of scalp (HP:0002293) | 1.65009812 |
144 | Abnormality of methionine metabolism (HP:0010901) | 1.64391909 |
145 | Tetraparesis (HP:0002273) | 1.63630257 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 3.10553528 |
2 | INSRR | 2.60276666 |
3 | TAOK3 | 2.44069756 |
4 | LATS1 | 2.37150834 |
5 | NUAK1 | 2.16594447 |
6 | DMPK | 2.15543016 |
7 | MAP4K1 | 2.14805336 |
8 | MAP3K13 | 2.05534834 |
9 | BLK | 2.04642057 |
10 | IRAK3 | 2.04610906 |
11 | JAK1 | 1.98533876 |
12 | PRPF4B | 1.93591746 |
13 | SIK1 | 1.82514290 |
14 | PIK3CG | 1.76017138 |
15 | FRK | 1.75458025 |
16 | IKBKE | 1.74555768 |
17 | FGFR3 | 1.73022693 |
18 | MAP3K3 | 1.67541791 |
19 | TXK | 1.65877079 |
20 | FGFR4 | 1.65649917 |
21 | TYK2 | 1.61588209 |
22 | CAMK1G | 1.59637628 |
23 | MAP3K7 | 1.58853478 |
24 | PRKAA2 | 1.43253609 |
25 | TNIK | 1.43216805 |
26 | EPHA3 | 1.43066018 |
27 | CAMK1D | 1.41339933 |
28 | NLK | 1.40473985 |
29 | SIK2 | 1.39839507 |
30 | EPHB1 | 1.38651030 |
31 | CDK12 | 1.37917762 |
32 | MARK2 | 1.36679766 |
33 | TNK2 | 1.32155311 |
34 | JAK3 | 1.27048969 |
35 | STK3 | 1.25925902 |
36 | TEC | 1.24148535 |
37 | IKBKB | 1.22860999 |
38 | ITK | 1.21865344 |
39 | KIT | 1.20240962 |
40 | TGFBR2 | 1.19900989 |
41 | SGK3 | 1.16645392 |
42 | TBK1 | 1.12740057 |
43 | AKT3 | 1.11973498 |
44 | SGK2 | 1.10869362 |
45 | MARK3 | 1.10309767 |
46 | CHUK | 1.10157704 |
47 | MAP2K3 | 1.10063733 |
48 | RIPK4 | 1.09626834 |
49 | PIK3CA | 1.07849348 |
50 | BMPR2 | 1.05685824 |
51 | YES1 | 1.05283056 |
52 | BRD4 | 1.03750339 |
53 | MAP3K6 | 1.01804458 |
54 | CAMKK2 | 0.98691785 |
55 | LYN | 0.98684017 |
56 | PRKD2 | 0.97394650 |
57 | PTK6 | 0.97100238 |
58 | TIE1 | 0.95062940 |
59 | HCK | 0.94916719 |
60 | TRIB3 | 0.94554635 |
61 | CSK | 0.93662920 |
62 | TAOK1 | 0.87230468 |
63 | JAK2 | 0.86101918 |
64 | PRKCQ | 0.85567508 |
65 | CDK6 | 0.84972824 |
66 | IRAK2 | 0.83956611 |
67 | STK10 | 0.82935444 |
68 | MAPK15 | 0.81719632 |
69 | FGFR2 | 0.81030388 |
70 | PIM1 | 0.79747141 |
71 | PDGFRB | 0.79604963 |
72 | WNK1 | 0.79005263 |
73 | SYK | 0.77743141 |
74 | NEK6 | 0.77375407 |
75 | ERN1 | 0.74803738 |
76 | MAPK7 | 0.74088137 |
77 | PRKCH | 0.73865946 |
78 | MAPK11 | 0.73538962 |
79 | PTK2B | 0.73536791 |
80 | MAP3K10 | 0.72366819 |
81 | CDK9 | 0.71994632 |
82 | RIPK1 | 0.70384908 |
83 | CDC42BPA | 0.70048552 |
84 | ZAP70 | 0.68941731 |
85 | MELK | 0.67873165 |
86 | CDK4 | 0.65975821 |
87 | IRAK4 | 0.65814118 |
88 | SGK223 | 0.65430976 |
89 | SGK494 | 0.65430976 |
90 | MAPK12 | 0.65277526 |
91 | STK24 | 0.64756311 |
92 | CAMKK1 | 0.61647890 |
93 | BTK | 0.61570755 |
94 | LCK | 0.60837083 |
95 | IGF1R | 0.60038832 |
96 | HIPK2 | 0.59846014 |
97 | MAP3K2 | 0.59683399 |
98 | SGK1 | 0.59272017 |
99 | FGR | 0.58735062 |
100 | ABL1 | 0.56207747 |
101 | MKNK2 | 0.55123565 |
102 | NEK9 | 0.54553197 |
103 | IRAK1 | 0.54132419 |
104 | CSF1R | 0.53904849 |
105 | MAP2K2 | 0.53692508 |
106 | EPHA4 | 0.53665381 |
107 | MAP3K1 | 0.52020000 |
108 | TRPM7 | 0.51948442 |
109 | RPS6KL1 | 0.51187904 |
110 | RPS6KC1 | 0.51187904 |
111 | RPS6KA6 | 0.50150634 |
112 | PDPK1 | 0.48896863 |
113 | STK11 | 0.48445184 |
114 | DYRK1B | 0.47544701 |
115 | SIK3 | 0.46602204 |
116 | FES | 0.45728072 |
117 | RET | 0.42597260 |
118 | EGFR | 0.42551074 |
119 | GRK6 | 0.41701011 |
120 | PRKAA1 | 0.41037384 |
121 | PDK1 | 0.40974490 |
122 | CAMK4 | 0.40502668 |
123 | MTOR | 0.39999465 |
124 | STK38 | 0.39885003 |
125 | PTK2 | 0.39644282 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.92494418 |
2 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79923162 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.77809611 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74368794 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.73541287 |
6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69098117 |
7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.66400611 |
8 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.64495424 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64434269 |
10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.64351590 |
11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59814568 |
12 | Lysine degradation_Homo sapiens_hsa00310 | 1.56796112 |
13 | ABC transporters_Homo sapiens_hsa02010 | 1.45719333 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45700952 |
15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.37230796 |
16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.35971638 |
17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.34196048 |
18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30866631 |
19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30358663 |
20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29112666 |
21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23253033 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22567016 |
23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.18512967 |
24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17097657 |
25 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13571087 |
26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13514834 |
27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12903123 |
28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12184266 |
29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09409825 |
30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09243841 |
31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08175898 |
32 | Insulin resistance_Homo sapiens_hsa04931 | 1.04745285 |
33 | Measles_Homo sapiens_hsa05162 | 1.04307890 |
34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03924661 |
35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03788738 |
36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02205213 |
37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01487696 |
38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01378470 |
39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00909923 |
40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.99170222 |
41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98868378 |
42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97814640 |
43 | Adherens junction_Homo sapiens_hsa04520 | 0.97502815 |
44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94825337 |
45 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93524169 |
46 | Influenza A_Homo sapiens_hsa05164 | 0.93070943 |
47 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92589248 |
48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92366341 |
49 | Platelet activation_Homo sapiens_hsa04611 | 0.92133314 |
50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90851860 |
51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90439977 |
52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87854240 |
53 | Bile secretion_Homo sapiens_hsa04976 | 0.87443747 |
54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86857295 |
55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86726219 |
56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85819816 |
57 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.85386549 |
58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84610726 |
59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84074246 |
60 | Asthma_Homo sapiens_hsa05310 | 0.84032583 |
61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83162680 |
62 | Legionellosis_Homo sapiens_hsa05134 | 0.82257951 |
63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81324577 |
64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80507640 |
65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80097119 |
66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79201278 |
67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79183655 |
68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79144542 |
69 | Apoptosis_Homo sapiens_hsa04210 | 0.78613923 |
70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.77902969 |
71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77543092 |
72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77504133 |
73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77174993 |
74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76351249 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76148431 |
76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75659367 |
77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75607053 |
78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73426507 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72964628 |
80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72567889 |
81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72326529 |
82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71501831 |
83 | Prostate cancer_Homo sapiens_hsa05215 | 0.71218221 |
84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69529899 |
85 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68822745 |
86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68414221 |
87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67551169 |
88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67065976 |
89 | Glioma_Homo sapiens_hsa05214 | 0.66555677 |
90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66523819 |
91 | Hepatitis C_Homo sapiens_hsa05160 | 0.65974870 |
92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64711328 |
93 | Hepatitis B_Homo sapiens_hsa05161 | 0.64065133 |
94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63970957 |
95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63687097 |
96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63234799 |
97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61462586 |
98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60700933 |
99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59937739 |
100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58098839 |
101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57851699 |
102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57532848 |
103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57422176 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57165347 |
105 | Pertussis_Homo sapiens_hsa05133 | 0.57055239 |
106 | Allograft rejection_Homo sapiens_hsa05330 | 0.57015433 |
107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56896527 |
108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56670671 |
109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56022603 |
110 | Tuberculosis_Homo sapiens_hsa05152 | 0.55950631 |
111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55748494 |
112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53958244 |
113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53713437 |
114 | Renin secretion_Homo sapiens_hsa04924 | 0.53637203 |
115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52472393 |
116 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52421236 |
117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52043189 |
118 | Peroxisome_Homo sapiens_hsa04146 | 0.51409456 |
119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51403826 |
120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50987580 |
121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50653470 |
122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50154198 |
123 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48759725 |
124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48321025 |
125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48225945 |
126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47922380 |
127 | Amoebiasis_Homo sapiens_hsa05146 | 0.47766970 |
128 | Malaria_Homo sapiens_hsa05144 | 0.47658417 |
129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47577313 |
130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47141358 |
131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46837238 |
132 | Mineral absorption_Homo sapiens_hsa04978 | 0.46550693 |
133 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45124208 |
134 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45103681 |
135 | Endocytosis_Homo sapiens_hsa04144 | 0.45054348 |
136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44723957 |
137 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44304382 |
138 | Focal adhesion_Homo sapiens_hsa04510 | 0.43679664 |
139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41517058 |